|
1
|
Activity of temozolomide in the treatment of central nervous system tumor xenografts.
|
Cancer Res
|
1995
|
1.52
|
|
2
|
Stress-related primary intracerebral hemorrhage: autopsy clues to underlying mechanism.
|
Stroke
|
2000
|
1.44
|
|
3
|
Additional risk factors in atrial fibrillation patients not receiving warfarin.
|
Age Ageing
|
1999
|
1.40
|
|
4
|
Therapeutic efficacy of the topoisomerase I inhibitor 7-ethyl-10-(4-[1-piperidino]-1-piperidino)-carbonyloxy-camptothecin against pediatric and adult central nervous system tumor xenografts.
|
Cancer Chemother Pharmacol
|
1997
|
1.25
|
|
5
|
Methylator resistance mediated by mismatch repair deficiency in a glioblastoma multiforme xenograft.
|
Cancer Res
|
1997
|
1.24
|
|
6
|
Schedule-dependent activity of temozolomide plus CPT-11 against a human central nervous system tumor-derived xenograft.
|
Clin Cancer Res
|
2000
|
1.16
|
|
7
|
Immunohistochemical co-localization of transient receptor potential vanilloid (TRPV)1 and sensory neuropeptides in the guinea-pig respiratory system.
|
Neuroscience
|
2006
|
1.07
|
|
8
|
Activity of 9-dimethylaminomethyl-10-hydroxycamptothecin against pediatric and adult central nervous system tumor xenografts.
|
Cancer Chemother Pharmacol
|
1994
|
1.00
|
|
9
|
Enhancement of irinotecan (CPT-11) activity against central nervous system tumor xenografts by alkylating agents.
|
Cancer Chemother Pharmacol
|
1998
|
1.00
|
|
10
|
Studies on enterovirus in patients with chronic fatigue syndrome.
|
Clin Infect Dis
|
1994
|
0.86
|
|
11
|
Modulation of cyclophosphamide activity by O6-alkylguanine-DNA alkyltransferase.
|
Cancer Chemother Pharmacol
|
1999
|
0.86
|
|
12
|
Basement membrane proteins in the space of Disse: a reappraisal.
|
J Clin Pathol
|
1991
|
0.83
|
|
13
|
Association between cognitive impairment and atrial fibrillation: a systematic review.
|
J Stroke Cerebrovasc Dis
|
2007
|
0.81
|
|
14
|
Acyl derivatives of demethylpenclomedine, an antitumor-active, non-neurotoxic metabolites of penclomedine.
|
Cancer Chemother Pharmacol
|
2001
|
0.81
|
|
15
|
The 2010 British Association of Stroke Physicians Survey of interventional treatments for stroke in the United Kingdom.
|
Int J Stroke
|
2013
|
0.80
|
|
16
|
Busulfan therapy of central nervous system xenografts in athymic mice.
|
Cancer Chemother Pharmacol
|
1994
|
0.80
|
|
17
|
Therapeutic efficacy of vinorelbine against pediatric and adult central nervous system tumors.
|
Cancer Chemother Pharmacol
|
1998
|
0.78
|
|
18
|
Prediction of outcome after stroke.
|
Lancet
|
2001
|
0.75
|
|
19
|
Enhancement of melphalan activity by inhibition of DNA polymerase-alpha and DNA polymerase-beta.
|
Cancer Chemother Pharmacol
|
1996
|
0.75
|
|
20
|
ACE inhibitors and diabetics with albuminuria.
|
Lancet
|
1995
|
0.75
|
|
21
|
Engraftment of C6-2B cells into the striatum of ACI nude rats as a tool for comparison of the in vitro and in vivo phenotype of a glioma cell line.
|
Cell Transplant
|
1997
|
0.75
|
|
22
|
Keynote address 2. Canadian National Conference on Occupational Health: Issues and Priorities.
|
Can J Public Health
|
1977
|
0.75
|
|
23
|
Health education. Advice given to coronary patients.
|
Nursing (Lond)
|
1990
|
0.75
|
|
24
|
Characterization of the mechanisms of busulfan resistance in a human glioblastoma multiforme xenograft.
|
Cancer Chemother Pharmacol
|
1997
|
0.75
|